180 related articles for article (PubMed ID: 22562434)
1. L-carnitine and cancer cachexia. I. L-carnitine distribution and metabolic disorders in cancer cachexia.
Szefel J; Kruszewski WJ; Ciesielski M; Szajewski M; Kawecki K; Aleksandrowicz-Wrona E; Jankun J; Lysiak-Szydłowska W
Oncol Rep; 2012 Jul; 28(1):319-23. PubMed ID: 22562434
[TBL] [Abstract][Full Text] [Related]
2. L-carnitine and cancer cachexia. II. Effects of lipid emulsion used in total parenteral nutrition on parameters of hemostasis and inflammatory state in L-carnitine deficiency in myocytes.
Szefel J; Kruszewski WJ; Ciesielski M; Szajewski M; Kawecki K; Jankun J; Lysiak-Szydłowska W
Oncol Rep; 2012 Jul; 28(1):324-9. PubMed ID: 22562458
[TBL] [Abstract][Full Text] [Related]
3. [Assay of carnitine in plasma and urine of healthy adults].
Niu YJ; Jiang ZM; Shu H; Li CF; Liu W; Yao GX; Jiang J; Li JQ; Longo A
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):185-7. PubMed ID: 12905800
[TBL] [Abstract][Full Text] [Related]
4. [Parenterally administered medium-chain triglyceride-induced changes in carnitine metabolism].
Rössle C; Carpentier YA; Richelle M; Dahlan W; D'Attellis NP; Elwyn DH; Stehle P; Fürst P
Infusionstherapie; 1991 Aug; 18(4):167-71. PubMed ID: 1937839
[TBL] [Abstract][Full Text] [Related]
5. Total carnitine and acylated carnitine ratio: relationship of free carnitine with lipid parameters in pediatric dialysis patients.
Marín VB; Azocar M; Molina M; Guerrero JL; Ratner R; Cano F
Adv Perit Dial; 2006; 22():130-5. PubMed ID: 16983956
[TBL] [Abstract][Full Text] [Related]
6. Serum interleukin-15 levels in cancer patients with cachexia.
Martínez-Hernández PL; Hernanz-Macías Á; Gómez-Candela C; Grande-Aragón C; Feliu-Batlle J; Castro-Carpeño J; Martínez-Muñoz I; Zurita-Rosa L; Villarino-Sanz M; Prados-Sánchez C; Sánchez García-Girón J
Oncol Rep; 2012 Oct; 28(4):1443-52. PubMed ID: 22825570
[TBL] [Abstract][Full Text] [Related]
7. The metabolic effects of two different lipid emulsions used in parenterally fed premature infants--a randomized comparative study.
Demirel G; Oguz SS; Celik IH; Erdeve O; Uras N; Dilmen U
Early Hum Dev; 2012 Jul; 88(7):499-501. PubMed ID: 22245235
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment.
Mancinelli A; D'Iddio S; Bisonni R; Graziano F; Lippe P; Calvani M
Cancer Chemother Pharmacol; 2007 Jun; 60(1):19-26. PubMed ID: 16988826
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of L-Carnitine in Plasma and Urine in Patients Undergoing Cisplatin Chemotherapy.
Gomi D; Tanaka A; Fukushima T; Kobayashi T; Matsushita H; Sekiguchi N; Sakamoto A; Sasaki S; Mamiya K; Koizumi T
Chemotherapy; 2017; 62(4):225-230. PubMed ID: 28419998
[TBL] [Abstract][Full Text] [Related]
10. Effects of parenteral structured lipid emulsion on modulating the inflammatory response in rats undergoing a total gastrectomy.
Lin MT; Yeh SL; Tsou SS; Wang MY; Chen WJ
Nutrition; 2009 Jan; 25(1):115-21. PubMed ID: 18834719
[TBL] [Abstract][Full Text] [Related]
11. Medium-chain triglycerides and long-term parenteral nutrition in children.
Goulet O; Postaire M; De Potter S; Boya I; Jouniaux AM; Bereziat G; Ricour C
Nutrition; 1992; 8(5):333-7. PubMed ID: 1358286
[TBL] [Abstract][Full Text] [Related]
12. Effect of acetyl-L-carnitine treatment on the levels of levocarnitine and its derivatives in streptozotocin-diabetic rats.
Marzo A; Corsico N; Cardace G; Morabito E
Arzneimittelforschung; 1993 Mar; 43(3):339-42. PubMed ID: 8489564
[TBL] [Abstract][Full Text] [Related]
13. The influence of kidney transplantation on carnitine metabolism.
Kohse KP; Dech E; Rössle C; Franz HE; Fürst P
Clin Nephrol; 1988 Apr; 29(4):199-205. PubMed ID: 3284670
[TBL] [Abstract][Full Text] [Related]
14. Short-term effects of parenteral nutrition of cholestatic infants with lipid emulsions based on medium-chain and long-chain triacylglycerols.
Socha P; Koletzko B; Demmelmair H; Jankowska I; Stajniak A; Bednarska-Makaruk M; Socha J
Nutrition; 2007 Feb; 23(2):121-6. PubMed ID: 17234505
[TBL] [Abstract][Full Text] [Related]
15. The effects of long- or medium-chain fat diets on glucose tolerance and myocellular content of lipid intermediates in rats.
De Vogel-van den Bosch J; Hoeks J; Timmers S; Houten SM; van Dijk PJ; Boon W; Van Beurden D; Schaart G; Kersten S; Voshol PJ; Wanders RJ; Hesselink MK; Schrauwen P
Obesity (Silver Spring); 2011 Apr; 19(4):792-9. PubMed ID: 20595951
[TBL] [Abstract][Full Text] [Related]
16. Evolution of lipid profile, liver function, and pattern of plasma fatty acids according to the type of lipid emulsion administered in parenteral nutrition in the early postoperative period after digestive surgery.
Puiggròs C; Sánchez J; Chacón P; Sabín P; Roselló J; Bou R; Planas M
JPEN J Parenter Enteral Nutr; 2009; 33(5):501-12. PubMed ID: 19420283
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor production by human mononuclear cells during total parenteral nutrition containing long-chain triglycerides.
Gogos CA; Zoumbos NC; Makri M; Kalfarentzos F
Nutrition; 1992; 8(1):26-9. PubMed ID: 1562785
[TBL] [Abstract][Full Text] [Related]
18. Carnitine deficiency disorders in children.
Stanley CA
Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
[TBL] [Abstract][Full Text] [Related]
19. Serum and urine levels of levocarnitine family components in genetically diabetic rats.
Morabito E; Corsico N; Marzo A; Arrigoni Martelli E
Arzneimittelforschung; 1994 Aug; 44(8):965-8. PubMed ID: 7945543
[TBL] [Abstract][Full Text] [Related]
20. Fat oxidation and plasma removal capacity of an intravenous fat emulsion in elderly and young men.
Aberg W; Thörne A; Olivecrona T; Nordenström J
Nutrition; 2006; 22(7-8):738-43. PubMed ID: 16815487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
